Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Extension to A record- funds for sequencing: Measuring the impact of naturally acquired immunity on the expression of Plasmodium falciparum variant surface antigens. (360G-Wellcome-084535_Z_07_B)

Plasmodium falciparum infected erythrocytes express on their surface, members of a diverse family of parasite molecules called PfEMP1 that are encoded by a family of 60 var genes. These molecules interact with the surface of host cells and mediate parasite sequestration in tissues including the brain, an important step in the pathogenesis of cerebral malaria. Although naturally acquired antibodies to PfEMP1 provide specific protection against the molecular variants that they recognise, PfEMP1 ar e often considered too diverse to be vaccine candidates. However, we and others have shown that parasites infecting children with severe malaria tend to express serotypes that are more broadly recognised suggesting they may be antigenically restricted. Studies of a laboratory isolate suggest that the most broadly recognised PfEMP1 types are encoded by a genetically distinct subset of groupA var genes. By sequencing short var sequence tags expressed in parasites from Kenya, we have shown that expression of sequences with groupA-like features are associated with younger children and that a smaller subset of these sequences are associated with severe malaria. We propose to identify new targets of malaria intervention by characterizing these specific subsets of PfEMP1 that are associated with infections of children with low natural immunity.

£34,024

31 Aug 2011

Grant details
Amount Awarded 34024
Applicant Surname Bull
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2011-08-31T00:00:00+00:00
Financial Year 2010/11
Grant Programme: Title Programme Grant
Internal ID 084535/Z/07/B
Lead Applicant Dr Peter Bull
Planned Dates: End Date 2009-08-31T00:00:00+00:00
Planned Dates: Start Date 2008-03-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region South East
Additional data added by GrantNav